Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked
一项针对携带EGFR敏感突变或从未吸烟的IV期非鳞状非小细胞肺癌患者的II期随机试验，比较了卡铂、培美曲塞和贝伐珠单抗联合或不联合阿特珠单抗的疗效。
期刊:Clinical Lung Cancer
影响因子:3.3
doi:10.1016/j.cllc.2023.05.003
Bodor, J Nicholas; Patel, Jyoti D; Wakelee, Heather A; Levy, Benjamin P; Borghaei, Hossein; Pellini, Bruna; Costello, Michael R; Dowell, Jonathan E; Finley, Gene; Huang, Chao H; Neal, Joel W; Nieva, Jorge J; Puri, Sonam; Socinski, Mark A; Thomas, Christian; Ross, Eric A; Litwin, Samuel; Clapper, Margie L; Treat, Joseph
